Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Cuprina Holdings (Cayman) Limited (CUPR)

3.9700 +1.5600 (+64.73%)
At close: 4:00:01 PM EDT
3.7200 -0.2500 (-6.30%)
After hours: 6:43:37 PM EDT
Chart Range Bar
Loading chart for CUPR
  • Previous Close 2.4100
  • Open 3.2602
  • Bid 3.3000 x 200
  • Ask 4.7200 x 200
  • Day's Range 3.2200 - 8.2299
  • 52 Week Range 1.7600 - 76.0000
  • Volume 83,129,563
  • Avg. Volume 340,610
  • Market Cap (intraday) 10.645M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -1.4100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste streams; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.

www.cuprina.com.sg

10

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 6/12/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CUPR
24.06%
S&P 500 (^GSPC)
8.56%

1-Year Return

CUPR
91.28%
S&P 500 (^GSPC)
22.93%

3-Year Return

CUPR
88.67%
S&P 500 (^GSPC)
71.27%

5-Year Return

CUPR
88.67%
S&P 500 (^GSPC)
74.96%

Statistics

View More

Valuation Measures

Annual
As of 6/11/2026
  • Market Cap

    6.46M

  • Enterprise Value

    4.42M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    159.63

  • Price/Book (mrq)

    1.65

  • Enterprise Value/Revenue

    114.45

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -58.90%

  • Return on Equity (ttm)

    -1,569.06%

  • Revenue (ttm)

    49.89k

  • Net Income Avi to Common (ttm)

    -4.67M

  • Diluted EPS (ttm)

    -1.4100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.2M

  • Total Debt/Equity (mrq)

    67.52%

  • Levered Free Cash Flow (ttm)

    -6M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

3.9700 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: